PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin in High Risk Patients Treated for Primary and Secondary Prevention of Cardiovascular Disease in Greece
Abstract
Authors
V. Fragoulakis G. Kourlaba N. Maniadakis